New forays into the pharma space and a billion-dollar discovery deal… What’s new in business?

Acetaminophen derivatives could offer patients a safer alternative to common pain management treatments.

Researchers identify several factors associated with shorter marketing exclusivity periods.

How can small molecule "degraders" help target disease-causing proteins?

New method to control polymorphism could see “widespread use across the pharma industry”.

How can companies be encouraged to develop treatments for the growing number of patients living with CNS disorders?

Formulation fit for the future of complex molecules.

Newly published research suggests that some excipients may be more "active" than previously thought.

Single-use systems have come a long way. We look at experience with the technology so far.

Can a medieval medicament find use as a modern antibacterial?